Skip to main content
Innoviva, Inc. (INVA)
NASDAQ: INVA · Real-Time Price · USD
23.69
+0.33 (1.41%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Innoviva Revenue

In the year 2025, Innoviva had annual revenue of $411.33M with 14.67% growth. Innoviva had revenue of $114.61M in the quarter ending December 31, 2025, with 24.84% growth.

Revenue (ttm)
$411.33M
Revenue Growth
+14.67%
P/S Ratio
4.26
Revenue / Employee
$2,586,969
Employees
159
Market Cap
1.75B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025411.33M52.62M14.67%
Dec 31, 2024358.71M48.25M15.54%
Dec 31, 2023310.46M-20.88M-6.30%
Dec 31, 2022331.34M-60.53M-15.45%
Dec 31, 2021391.87M55.07M16.35%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Harmony Biosciences Holdings 868.45M
Syndax Pharmaceuticals 172.35M
Recursion Pharmaceuticals 74.68M
Nurix Therapeutics 71.78M
Vir Biotechnology 68.56M
Nanobiotix 38.27M
Taysha Gene Therapies 9.77M
Oculis Holding AG 1.51M
Revenue Rankings

INVA News

More News